MENS
Jyong Biotech Ltd. Ordinary Shares
NASDAQ: MENS · HEALTHCARE · BIOTECHNOLOGY
$2.06
-2.83% today
Updated 2026-09-16
Market cap
$161.18M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$1 – $67
Volume
0.0M
Jyong Biotech Ltd. Ordinary Shares (MENS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 1
Last 1 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
When is the next earnings report?
Reporting date
June 30, 2026
Consensus EPS estimate
—
Fiscal period ending
2026-06-30
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-06-30 | — | — | — | — | — |
| 2025-03-31 | $0.00 | $-0.02 | — | — | — |
Frequently asked questions
When does Jyong Biotech Ltd. Ordinary Shares report next earnings?
Jyong Biotech Ltd. Ordinary Shares (MENS) is scheduled to report earnings on June 30, 2026.
Has Jyong Biotech Ltd. Ordinary Shares beaten earnings estimates?
Jyong Biotech Ltd. Ordinary Shares has beaten Wall Street EPS estimates in 0 of its last 1 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.